Manon Valiquette - Publications

Affiliations: 
Biochemistry and Molecular Medicine Université de Montréal, Montréal, Canada 

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Peters MF, Vaillancourt F, Heroux M, Valiquette M, Scott CW. Comparing label-free biosensors for pharmacological screening with cell-based functional assays. Assay and Drug Development Technologies. 8: 219-27. PMID 20085460 DOI: 10.1089/adt.2009.0232  0.59
1995 Valiquette M, Parent S, Loisel TP, Bouvier M. Mutation of tyrosine-141 inhibits insulin-promoted tyrosine phosphorylation and increased responsiveness of the human beta 2-adrenergic receptor. The Embo Journal. 14: 5542-9. PMID 8521811 DOI: 10.1002/J.1460-2075.1995.Tb00241.X  0.587
1995 Bouvier M, Nantel F, Valiquette M, Moffett S, Mouillac B. Le récepteur β2-adrénergique. Un modèle d'étude des mécanismes moléculaires de la désensibilisation MéDecine/Sciences. 11: 819. DOI: 10.4267/10608/2293  0.509
1993 Valiquette M, Bonin H, Bouvier M. Mutation of tyrosine-350 impairs the coupling of the beta 2-adrenergic receptor to the stimulatory guanine nucleotide binding protein without interfering with receptor down-regulation. Biochemistry. 32: 4979-85. PMID 8388251 DOI: 10.1021/Bi00070A002  0.606
1990 Valiquette M, Bonin H, Hnatowich M, Caron MG, Lefkowitz RJ, Bouvier M. Involvement of tyrosine residues located in the carboxyl tail of the human beta 2-adrenergic receptor in agonist-induced down-regulation of the receptor. Proceedings of the National Academy of Sciences of the United States of America. 87: 5089-93. PMID 2164220 DOI: 10.1073/Pnas.87.13.5089  0.626
Show low-probability matches.